NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIA E-049-2001-0-US-23 GLP-1, Exendin-4, Peptide Analogs and Uses Thereof US CON 14/470,528 10941187 Issued PDF
NEI E-164-2014-0-US-01 METHODS AND COMPOSITIONS FOR TREATING LEBER CONGENITAL AMAUROSIS US 62/042,703 Abandoned
NIA E-224-2014-0-US-01 External Peripheral Vascular Occlusion For Enhanced CardioPulmonary Resuscitation US 62/042,588 Abandoned
NIDA E-199-2015-0-US-01 Method And Apparatus For The Capture Of Intra-cellular Activity (Nanofids) US 62/041,028 Abandoned
NCATS E-088-2016-0-CA-03 5-AMINO 4-CYANO SUBSTITUTED OXAZOLE AND THIAZOLE DERIVATIVES AS INHIBITORS OF HUMAN 12/15-LIPOXYGENASE CA National Stage 2924141 Issued
NIBIB E-005-2012-2-US-05 Multi-Focal Structured Illumination Microscopy Systems and Methods US National Stage 14/380,392 9696534 Issued PDF
NCATS E-088-2016-0-PCT-02 Inhibitors Of 12/15-Lipoxygenase PCT PCT PCT/US2014/052269 Expired
CC E-199-2012-0-US-03 COMPUTED TOMOGRAPHY (CT) - HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) SYSTEM AND/OR METHOD US National Stage 14/380,418 Abandoned
NIAID E-212-2014-0-US-01 Chimeric Antigen Receptor To Control HIV Infection US 62/040,398 Abandoned
NIAID E-219-2014-0-US-03 Compounds For Inhibiting 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase US National Stage 14/130,384 9593136 Issued PDF
NINDS E-235-2014-0-US-01 BIOMARKERS FOR DIAGNOSIS AND MANAGEMENT OF NEURO-IMMUNOLOGICAL DISEASES US 62/038,530 Abandoned
NICHD E-057-2008-0-IL-49 Use Of Ulipristal For Treating Uterine Fibroids IL DIV 234149 Issued
NINDS E-143-2002-1-JP-43 Method For the Treatment of Multiple Sclerosis JP DIV 2014-147314 Abandoned
NIMH E-345-2013-0-PCT-02 Monitoring The Effects Of Sleep Deprivation Using Neuronal Avalanches PCT PCT PCT/US2014/051234 Expired
NIMH E-345-2013-0-EP-05 Monitoring The Effects Of Sleep Deprivation Using Neuronal Avalanches EP National Stage 14756200.3 Abandoned
NIMH E-345-2013-0-CA-04 Monitoring The Effects Of Sleep Deprivation Using Neuronal Avalanches CA National Stage 2921405 Abandoned
NIMH E-345-2013-0-AU-03 Monitoring The Effects Of Sleep Deprivation Using Neuronal Avalanches AU National Stage 2014306458 Abandoned
NIDCR E-066-1996-0-US-11 AAV4 VECTOR AND USES THEREOF US CON 14/459,550 Abandoned
NCI E-117-2011-0-HK-33 Recombinant Immunotoxin Targeting Mesothelin HK DIV 14108273.5 Abandoned
NIAID E-050-1997-1-US-21 DEVICE AND METHOD FOR AMPLIFYING TARGET NUCLEIC ACID US CON 14/456,592 9506105 Expired PDF
NCI E-205-2009-0-US-09 Anti-Vascular Endothelial Growth Factor Receptor-2 Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer US DIV 14/454,820 9522955 Abandoned PDF
NIA E-013-2010-0-AU-09 THE USE OF FENOTEROL AND FENOTEROL ANALOGUES IN THE TREATMENT OF GLIOBLASTOMAS AND ASTROCYTOMAS AU DIV 2014210656 Issued
NCI E-025-2009-0-NZ-22 Ratio Based Biomarkers And Methods of Use Thereof NZ DIV 628463 Issued
NCI E-209-2014-0-US-01 PHOTO-CONTROLLED REMOVAL OF TARGETS IN VITRO AND IN VIVO US 62/034,990 Abandoned
CC E-110-2014-0-US-01 Targeting CD36 Utilizing Synthetic Amphipathic Peptide Antagonists To Prevent Pulmonary Infection, Inflammation And Lung Injury US 62/035,161 Abandoned
NCI E-158-2014-0-US-01 HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR 5T4 AND METHODS OF THEIR USE US 62/034,995 Abandoned
NINDS E-025-2012-0-US-06 Methods of Treating and Preventing Diseases and Disorders of the Central Nervous System US National Stage 14/377,348 9308163 Issued PDF
NCI E-034-2010-0-US-05 Beta-Mannosylceramide and Stimulation of NKT Cell Anti-Tumor Immunity US CON 14/453,829 9168291 Issued PDF
NIDDK E-210-2014-0-US-01 A3 Adenosine Receptor Agonists US 62/033,723 Abandoned
NIAID E-253-2011-4-US-01 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE US CON 14/450,773 10047147 Issued PDF
NHLBI E-243-2009-0-US-04 Method For The Treatment Of Pulmonary Disease And Method of Producing Proteins Of Use Therein US DIV 14/450,512 Abandoned
NIA E-205-2006-2-HK-21 Preparation Of R,R- Fenoterol And R,R OR R,S Fenoterol Analogues And Their Use In Treating Congestive Heart Failure HK National Stage 14107948.2 Abandoned
NIAID E-043-2014-1-US-01 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE US 62/032,886 Abandoned
NCI E-508-2013-2-CA-04 INHIBITORS OF THE FARNESOID X RECEPTOR AND USES IN MEDICINE CA National Stage 2920017 Issued
NCI E-508-2013-2-AU-02 INHIBITORS OF THE FARNESOID X RECEPTOR AND USES IN MEDICINE AU National Stage 2014296023 Issued
NCI E-508-2013-2-FR-14 INHIBITORS OF THE FARNESOID X RECEPTOR AND USES IN MEDICINE FR EP 14752716.2 Issued
NCI E-508-2013-2-DE-13 INHIBITORS OF THE FARNESOID X RECEPTOR AND USES IN MEDICINE DE EP 14752716.2 Issued
NCI E-508-2013-2-EP-06 INHIBITORS OF THE FARNESOID X RECEPTOR AND USES IN MEDICINE EP National Stage 14752716.2 Issued
NCI E-508-2013-2-GB-15 INHIBITORS OF THE FARNESOID X RECEPTOR AND USES IN MEDICINE GB EP 14752716.2 Issued
NCI E-262-2005-0-AU-22 Mutated Pseudomonas Exotoxins with Reduced Immunogenicity AU DIV 2014208269 Issued
NCI E-508-2013-2-PCT-01 INHIBITORS OF THE FARNESOID X RECEPTOR AND USES IN MEDICINE PCT PCT COMB PCT/US2014/049460 Expired
NCI E-508-2013-2-IN-07 INHIBITORS OF THE FARNESOID X RECEPTOR AND USES IN MEDICINE IN National Stage 201647006033 Issued
NCI E-162-2014-0-US-01 HUMAN MONOCLONAL ANTIBODIES (MABS) AGAINST EPHA4 AND THEIR USE US 62/031,793 Abandoned
NHLBI E-068-2016-0-US-01 The Effect Of Phospholipid Composition Of Reconstituted HDL On Its Cholesterol Efflux And Anti-inflammatory Properties US 62/031,705 Abandoned
NINDS E-030-2013-0-EP-03 11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists EP National Stage 14750663.8 Issued
NINDS E-030-2013-0-US-04 11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists US National Stage 14/908,271 9550742 Issued PDF
NINDS E-030-2013-0-PCT-02 Selective Human D2 Dopamine Receptor Antagonists And Methods Of Their Use PCT PCT PCT/US2014/048619 Expired
NCI E-121-2015-0-PCT-02 Inhibition Of Plasminogen Activator Inhibitor-1 (PAI-1) Activity Mitigates Radiation Fibrosis PCT PCT PCT/US14/048604 Expired
CC E-093-2014-0-US-01 FREE HORMONE AND HORMONE METABOLITE WORKUP AND ANALYSIS BY MASS SPECTROMETRY US 62/030,459 Abandoned
NIAID E-223-2014-0-US-01 Compositions and Methods for Inhibiting Human Immunodeficiency Virus Budding US 62/030,193 Abandoned